Literature DB >> 18030412

Postoperative chylothorax development is associated with increased incidence and risk profile for central venous thromboses.

M A McCulloch1, M R Conaway, J A Haizlip, M L Buck, V E Bovbjerg, T R Hoke.   

Abstract

This study tested the hypothesis that pediatric patients who develop chylothorax (CTX) after surgery for congenital heart disease (CHD) have an elevated incidence and risk profile for central venous thrombosis (CVT). We evaluated 30 patients who developed CTX after surgery for CHD. All but one CTX patient were surgery-, anatomy-, and age-matched with two controls (NON-CTX) to compare their relative risk and incidence of CVT. Using conditional logistic regression analyses, CTX development was associated with significantly longer ventilator dependence (14.8 +/- 10.9 vs. 6.1 +/- 5.9 days, p = 0.003) and a non-significant trend towards more days of central venous catheters (CVC) (19.1 +/- 16.6 vs. 12.2 +/- 10.0 days; p = 0.16) when comparing the period prior to CTX development with the entire hospitalization in NON-CTX patients. CTX development was associated with a significantly elevated mortality risk (Odds Ratio 6.2, 95% CI 1.3-30.9). Minimum and mean daily central venous pressures were significantly higher in the CTX group. Post operative need for extracorporeal membrane oxygenation conferred an increased risk of CTX development in this sample of patients (Odds Ratio 9.9, 95% CI 2.2-44.8). Incidence of documented CVT was 26.7% in the CTX group versus 5.1% in the NON-CTX group. Prospective screening for CVT risk and formation, combined with early removal of CVC may help reduce the incidence of CTX.

Entities:  

Mesh:

Year:  2007        PMID: 18030412     DOI: 10.1007/s00246-007-9140-9

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  33 in total

1.  Somatostatin in the treatment of chylothorax.

Authors:  N J Demos; J Kozel; J E Scerbo
Journal:  Chest       Date:  2001-03       Impact factor: 9.410

2.  Octreotide in the management of postoperative chylothorax.

Authors:  L Rosti; F De Battisti; G Butera; S Cirri; M Chessa; A Delogu; M Drago; A Giamberti; G Pomè; M Carminati; A Frigiola
Journal:  Pediatr Cardiol       Date:  2005 Jul-Aug       Impact factor: 1.655

3.  Antithrombin activity in children with chylothorax.

Authors:  Vera Bernet-Buettiker; Katharina Waldvogel; Vincenzo Cannizzaro; Manuela Albisetti
Journal:  Eur J Cardiothorac Surg       Date:  2006-01-24       Impact factor: 4.191

4.  Treatment of a persistent postoperative chylothorax with somatostatin.

Authors:  P C Rimensberger; B Müller-Schenker; A Kalangos; M Beghetti
Journal:  Ann Thorac Surg       Date:  1998-07       Impact factor: 4.330

5.  Superior vena cava thrombosis and chylothorax: relationship in pediatric nephrotic syndrome.

Authors:  J Hanna; E Truemper; E Burton
Journal:  Pediatr Nephrol       Date:  1997-02       Impact factor: 3.714

6.  Octreotide efficacy in the treatment of chylothoraces following cardiac surgery in infants and children.

Authors:  Maple T Landvoigt; Charles J Mullett
Journal:  Pediatr Crit Care Med       Date:  2006-05       Impact factor: 3.624

7.  Octreotide as a therapeutic option for management of chylothorax.

Authors:  Sulaiman A Al-Zubairy; Abdulrazaq S Al-Jazairi
Journal:  Ann Pharmacother       Date:  2003-05       Impact factor: 3.154

8.  Postoperative chylothorax after cardiothoracic surgery in children.

Authors:  Emily H Chan; Jennifer L Russell; William G Williams; Glen S Van Arsdell; John G Coles; Brian W McCrindle
Journal:  Ann Thorac Surg       Date:  2005-11       Impact factor: 4.330

9.  Treatment of refractory chylothorax with externalized pleuroperitoneal shunts in children.

Authors:  A B Wolff; M L Silen; E R Kokoska; B M Rodgers
Journal:  Ann Thorac Surg       Date:  1999-09       Impact factor: 4.330

Review 10.  Use of Monogen for pediatric postoperative chylothorax.

Authors:  Barbara E Cormack; Nigel J Wilson; Kirsten Finucane; Teena M West
Journal:  Ann Thorac Surg       Date:  2004-01       Impact factor: 4.330

View more
  6 in total

Review 1.  Postoperative Acute Pulmonary Embolism Following Pulmonary Resections.

Authors:  Felix Samuel Shonyela; Shuangqiang Yang; Bo Liu; Jia Jiao
Journal:  Ann Thorac Cardiovasc Surg       Date:  2015-09-09       Impact factor: 1.520

2.  Chylothorax after surgery on congenital heart disease in newborns and infants -risk factors and efficacy of MCT-diet.

Authors:  Eva S Biewer; Christoph Zürn; Raoul Arnold; Martin Glöckler; Jürgen Schulte-Mönting; Christian Schlensak; Sven Dittrich
Journal:  J Cardiothorac Surg       Date:  2010-12-13       Impact factor: 1.637

3.  Post-operative Chylothorax in Patients with Repaired Transposition of the Great Arteries.

Authors:  Danish Vaiyani; Madhumitha Saravanan; Yoav Dori; Erin Pinto; Matthew J Gillespie; Jonathan J Rome; David J Goldberg; Christopher L Smith; Michael L O'Byrne; Aaron G DeWitt; Chitra Ravishankar
Journal:  Pediatr Cardiol       Date:  2021-11-29       Impact factor: 1.655

4.  Treatment of chylothorax developed after congenital heart disease surgery: a case report.

Authors:  Ozgul Bulut; Doruk Gul; Sibel Sevuk; Ilke Mungan; Derya Buyukkayhan
Journal:  North Clin Istanb       Date:  2015-12-25

Review 5.  Diagnosis and Management of Lymphatic Disorders in Congenital Heart Disease.

Authors:  Benjamin Kelly; Sheyanth Mohanakumar; Vibeke Elisabeth Hjortdal
Journal:  Curr Cardiol Rep       Date:  2020-10-10       Impact factor: 2.931

6.  Effect of Minocycline Pleurodesis in Infants With Refractory Chylothorax After Palliative Surgery for Complex Congenital Heart Disease.

Authors:  Kanchi Saito; Hirofumi Saiki; Shigekuni Tsuchiya; Yurie Takizawa; Akira Sato; Takuya Goto; Yukiko Toya; Atsushi Matsumoto; Junichi Koizumi; Kotaro Oyama; Manami Akasaka
Journal:  Cureus       Date:  2022-03-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.